Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtrer
1.
J Affect Disord ; 184: 256-60, 2015 Sep 15.
Article de Anglais | MEDLINE | ID: mdl-26118753

RÉSUMÉ

Prevalence of depression is high in patients with chronic heart failure (CHF), and depressive mood is considered as a risk factor for major cardiovascular events and mortality in CHF patients. The validity of self-administered 21-item Beck Depression Inventory (BDI) in CHF patients might be questioned. CHF actually shares overlapping symptoms with depression and such an overlap may overestimate the impact of depression on cardiac outcomes. We tested the convergent validity of the French version of BDI by reference to the interview-based Montgomery Asberg Depression Rating Scale (MADRS) in a population of 73 patients participating in the multicenter French PANIC Cohort of 321 CHF patients. Both depression scores were associated with NYHA functional class and the number of previous hospitalizations related to CHF, but not with the other indexes of cardiac severity (left ventricular ejection fraction and 6-min-walk test). MADRS scores were also associated with gender and history of depression. A strong correlation was found between BDI and MADRS scores (rho = 0.72; p < 0.001). This correlation persisted after adjustment for gender, NYHA functional class, number of previous hospitalizations and history of depression (rho = 0.68; p < 0.001). Moreover, the z score difference between standardized BDI and standardized MADRS scores was associated with none of the sociodemographic or clinical characteristics of our population, except for the depression severity at MADRS. In particular, no overestimation or underestimation of self-assessed depression was found in case of more severe CHF. These findings suggest that the BDI is a reliable instrument to assess depression in CHF patients.


Sujet(s)
Dépression/complications , Dépression/diagnostic , Défaillance cardiaque/complications , Défaillance cardiaque/psychologie , Échelles d'évaluation en psychiatrie/normes , Maladie chronique , Femelle , Hospitalisation , Humains , Mâle , Adulte d'âge moyen
2.
Gen Hosp Psychiatry ; 37(1): 94-5, 2015.
Article de Anglais | MEDLINE | ID: mdl-25583217

RÉSUMÉ

Intraoperative awareness is an unwanted outcome that consists of an explicit recall of events during a surgical procedure performed under general anesthesia. Despite its relatively infrequent occurrence, intraoperative awareness is of significant concern due to frequent adverse psychiatric sequelae. We present three patients who developed posttraumatic sequelae following an episode of awareness under anesthesia and discuss the importance of early detection and specific care.


Sujet(s)
Conscience peropératoire/psychologie , Troubles de stress post-traumatique/étiologie , Adulte , Sujet âgé , Femelle , Humains , Mâle , Adulte d'âge moyen , Jeune adulte
3.
Horm Metab Res ; 44(5): 354-8, 2012 May.
Article de Anglais | MEDLINE | ID: mdl-22517555

RÉSUMÉ

The aim of the work was to define quality criteria for presymptomatic genetic testing in minors at risk of paraganglioma/pheochromocytoma. A 3-step multidisciplinary procedure was developed: 1) preparatory consultations for parents, providing decision support and advice concerning the way of informing the children; 2) consultation with the minor and blood sampling; and 3) announcement of the result of the genetic test to the minor and his/her parents. Twenty-three minors (mean age=9.22) were tested. The result was positive in 16 cases (presence of the familial mutation) and negative in 7. The 23 procedures were classified according to emotional reactions at the announcement of the result: calm (18/23) or tense (5/23). In parallel, 4 criteria for a good testing procedure was defined: 1) both parents agreeing to have their child tested when they felt ready; 2) parents being given advice concerning the way to inform their child; 3) the most appropriate time for testing being discussed for each child; and 4) avoidance of testing during medical examination periods for the carrier parent. The frequencies of the above criteria were as follows: 1 (17/23); 2 (19/23); 3 (17/23); and 4 (17/23). The overall quality of the testing procedure, calculated as the sum of the four criteria, differed significantly between calm and tense announcements (p<0.01). This study highlights the important role of careful preparation with the parents in emotional acceptance of the result of testing. The 4 criteria identified should be evaluated in further prospective studies.


Sujet(s)
Tumeurs de la surrénale/génétique , Dépistage génétique/méthodes , Paragangliome/génétique , Phéochromocytome/génétique , Adolescent , Tumeurs de la surrénale/diagnostic , Tumeurs de la surrénale/épidémiologie , Tumeurs de la surrénale/psychologie , Enfant , Enfant d'âge préscolaire , Femelle , Conseil génétique , Humains , Mâle , Mineurs/psychologie , Paragangliome/diagnostic , Paragangliome/épidémiologie , Paragangliome/psychologie , Parents/psychologie , Phéochromocytome/diagnostic , Phéochromocytome/épidémiologie , Phéochromocytome/psychologie , Études prospectives , Facteurs de risque
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE